Avanos Medical (AVNS) Enterprise Value (2016 - 2025)
Avanos Medical (AVNS) has disclosed Enterprise Value for 13 consecutive years, with -$89.8 million as the latest value for Q4 2025.
- Quarterly Enterprise Value rose 16.62% to -$89.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$89.8 million through Dec 2025, up 16.62% year-over-year, with the annual reading at -$89.8 million for FY2025, 16.62% up from the prior year.
- Enterprise Value hit -$89.8 million in Q4 2025 for Avanos Medical, down from -$70.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$70.5 million in Q3 2025 to a low of -$127.7 million in Q4 2022.
- Historically, Enterprise Value has averaged -$97.8 million across 5 years, with a median of -$97.4 million in 2021.
- Biggest five-year swings in Enterprise Value: surged 46.67% in 2021 and later dropped 27.97% in 2025.
- Year by year, Enterprise Value stood at -$118.5 million in 2021, then decreased by 7.76% to -$127.7 million in 2022, then skyrocketed by 31.32% to -$87.7 million in 2023, then fell by 22.81% to -$107.7 million in 2024, then grew by 16.62% to -$89.8 million in 2025.
- Business Quant data shows Enterprise Value for AVNS at -$89.8 million in Q4 2025, -$70.5 million in Q3 2025, and -$90.3 million in Q2 2025.